PennyToBuck.com

MSLP’s top management has extensive experience in the sports world and has harnessed this drive and focus into building a business to benefit its customers and help Fuel The Athlete Inside™.

Headquartered in Denver, Colorado, the company is a fast-growing developer and manufacturer of safe, scientifically approved nutritional supplements that are free of banned substances and tested by athletes. They are designed to help athletes, bodybuilders, weightlifters and fitness enthusiasts improve their performance. Each and every MusclePharm product is the end result of an advanced six-stage research and testing protocol involving the expertise of top nutrition scientists. In addition, the products have been field-tested by more than 100 elite professional athletes from the NFL, MMA, MLB and elsewhere.

To date, the company has developed eight products: ASSAULT®, BATTLE FUEL®, BULLET PROOF®, COMBAT POWDER®, RECON®, SHRED MATRIX®, and MUSCLEGEL®. Two additional products are due in stores in 2010. MusclePharm products offer up to twice as much of the active ingredients per serving as competing products and incorporate a proprietary mix of ingredients not available elsewhere, such as Suma root– the “Russian Secret.” Suma is a natural, performance-boosting, strength-and muscle-building herbal derivative that has been used for years by top Russian athletes.

Are you too old to be healthy?

How about looking at a stock that may pack a real punch.

About MSLP at: www.musclepharm.com

GT Solar International, Inc. (NASDAQ: SOLR), a global provider of polysilicon production technology, and sapphire and silicon crystalline growth systems and materials for the solar, LED and other specialty markets, today announced the SDR™400 next generation CVD reactor for the production of high purity polysilicon. The SDR400 reactor can produce greater than 400 metric tons annually (MTA) of polysilicon. The new SDR400 also lowers electricity consumption by approximately 20 percent for each kilogram of polysilicon produced over the company’s previous generation reactor, the SDR300.

“Our new SDR400 CVD reactor further extends our polysilicon production technology leadership,” said Dave Keck, vice president and general manager of GT Solar’s polysilicon division. “Customers can produce 33 percent more polysilicon annually in the same footprint using approximately 20 percent less electricity for every kilogram of polysilicon produced. This lowers their cost of ownership and strengthens their competitive position.”

More about SOLR at: www.gtsolar.com

MetLife, Inc. (NYSE: MET) announced recently that its office at 13045 Tesson Ferry Road has earned an ENERGY STAR rating from the United States Environmental Protection Agency (EPA) for its superior energy performance and management.

This latest achievement marks MetLife’s 13th ENERGY STAR-rated owned and/or operated property. Additionally, six company owned and/or operated properties have received Leadership in Energy & Environmental Design (LEED) certifications from the United States Green Building Council (USGBC). MetLife’s energy management policy as well as other sustainability initiatives have enabled the company to reduce its energy consumption by more than 16% since 2006.

More about MET at: www.metlife.com

For FREE Daily Stock Alerts & Updates Signup At: http://pennytobuck.com/signup

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer ( http://pennytobuck.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyToBuck.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations.The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received twenty five thousand dollars in cash and twenty five thousand dollars in free trading stock from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (MSLP.OB).

<<

PROTEONOMIX, INC. (OTC.BB:PROT.OB), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced today that Mr. Michael Cohen, Chairman and CEO, is scheduling a multi-city European road trip to create additional awareness of the Proteonomix, Inc. investment opportunity to institutional investors.

Scheduled for early October, Mr. Cohen will discuss with sophisticated investors the recent contract to establish a joint venture with a group of investors that will establish a new stem cell treatment and research facility in the United Arab Emirates (U.A.E.). In addition, Mr. Cohen will discuss the opportunity to set up additional joint ventures in other countries using the U.A.E. arrangement as a model.

The recent contract calls for the joint venture partner to invest $5 million on or before September 10, 2010 in a Joint Venture company, XGEN Medical LLC. (”XGen”), a Nevis Island limited liability company.

XGen will purchase Proteoderm at a wholesale price of 50% of the Manufacturer’s Suggested Retail Price (MSRP). XGen will maintain exclusive distribution rights in the U.A.E., provided the Joint Venture purchases a minimum order of 5,000 units the first year, and increases purchases at a rate of 20% per annum until reaching 10,000 units per year. All terms of the agreement are subject to normal due diligence provisions.

PROT is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteoderm, Inc. is a wholly owned subsidiary of Proteonomix that has recently opened its retail web site, Proteoderm.com, and begun accepting pre-orders for its anti-aging line of skin care products. StromaCel, Inc.’s goal is the development therapeutic modalities for the treatment of Cardiovascular Disease (CVD). StromaCel, Inc. is pursuing the licensing of other technologies for therapeutic use. National Stem Cell, Inc. is Proteonomix’s operating subsidiary.

About PROT at: www.proteonomix.com

MusclePharm Corporation (OTCBB:MSLP.OB), one of the fastest growing nutritional supplement companies in the United States with a proprietary formulation used in eight performance products, has announced MuscleGel achieves NSF certification. In addition, the Company’s Recon and Assault nutritional products will be NSF certified within the coming months.

MSLP declared the appointment of Mariel Selbovitz, MPH, as Director of Global Therapeutics Product Procurement Development. Ms. Selbovitz is a graduate of Cornell University and received her Master’s in Public Health at the Johns Hopkins University Bloomberg School of Health. She worked as the Client Intake Specialist at Positive Health Project and Syringe Exchange Program Coordinator at the Foundation for Research on Sexually Transmitted Diseases and is a partner in BioEquity Partners

Selbovitz is also a member of the Cornell AIDS Clinical Trials Group Community Advisory Board and AIDS Treatment Advocacy Coalition. She presented at the 5th European Conference on Clinical and Social Research on AIDS and Drugs, International Conference on Antiviral Research, 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention and XVIII International AIDS Conference.

MSLP products are currently available in 1,200 of the top General Nutrition Centers (GNC) in the United States, as well as Vitamin Shop. MusclePharm’s award-winning products — Assault, Battle Fuel, Bullet Proof, Combat Powder, Recon and Shred Matrix—are also available online at gnc.com, bodybuilding.com, amazon.com and many other locations.

About MSLP at: www.musclepharm.com

For FREE Daily Stock Alerts & Updates Signup At: http://pennytobuck.com/signup

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer ( http://pennytobuck.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyToBuck.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations.The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received twenty thousand dollars in cash and twenty thousand dollars in free trading shares from a third party (Swiss Financial Report) for (30) days of advertisement services for Proteonomix, Inc. (PROT.OB). Crown Equity Holdings Inc. (CRWE.OB) has received twenty five thousand dollars in cash and twenty five thousand dollars in free trading stock from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (MSLP.OB).

Reported by: Emon CRWE Newswire Middle East correspondent.

President Barack Obama signed an executive order extending sanction against North Korea. Hoping to bring N. Korea in line with the rest of the world, but these sanctions are expected by major think tanks to have kittle results.

U.S Finance Ministry in this regard has distributed an additional list of organizations and individuals of DPRK, whose assets will be frozen in connection with their involvement in the missile and nuclear programs.

On this lists, U.S will freeze four North Korean individuals, three companies and five government agencies. Will Brown and Root, Bechtel, and Halliburton be among those listed?

The intention to impose new sanctions against North Korea was announced last month in South Korea, by Secretary of State Hillary Clinton. She said the restrictions are aimed at “selling and buying of arms and related materials, luxury goods, as well as other illegal activities.” And also include the freezing of bank accounts of individuals.
The North Korean regime has been under pressure because of tightened sanctions, shriveling trade amid increased international isolation, food shortages and a poor currency reform last year.

But the issue remains will these sanctions really make a difference or will North Korea become more antagonistic towards the west and our allies. in short, what will work to bring N. Korea into the fold, the carrot, or the stick?

********************************************************************

The Views and Opinions Expressed by the author are his or her opinions only and do not necessarily reflect those of this Web-Site or its agents, affiliates, officers, directors, staff, or contractors. The author at the time of this article did not own any shares or receive any consideration financial or otherwise from any company or person mentioned or referred to in the article.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWENewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWENewswire.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) Rule 17B requires disclosure of payment for investor relations.

Reported by: Emon CRWE Newswire Middle East correspondent.

Scientists have deciphered the genome of wheat, ta revolution in agriculture is coming.

British scientists were finally able to decipher the genome of wheat, which is one of the world’s oldest and most staple and important crops.

Because of this discovery, the researchers said in the coming years we will be capable of bringing disease-resistant wheat varieties to market.

By this development scientists hope to help the global staple to meet the challenges of climate change, disease and population growth.

A member of the research team Anthony Hall said that “the procurement of wheat is under great pressure, especially by the failure of production in Russia, which greatly increases prices. It is expected that in the next 40 years food production will have to increase by 50% and development of wheat varieties that require low input and provide a high performance is essential to manage the increased demand”.

As a consequence, we will speak about reducing the price of bread and improve food security worldwide. The results of the study can look to any producer of wheat.

********************************************************************

The Views and Opinions Expressed by the author are his or her opinions only and do not necessarily reflect those of this Web-Site or its agents, affiliates, officers, directors, staff, or contractors. The author at the time of this article did not own any shares or receive any consideration financial or otherwise from any company or person mentioned or referred to in the article.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWENewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWENewswire.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) Rule 17B requires disclosure of payment for investor relations.

EnergySolutions, Inc. (NYSE: ES) declined by 0.20%, closed at $4.94 and overall traded volume was 1.05 million shares while earning per share remains $0.14.

8×8, Inc. (NASDAQ: EGHT) advanced by 3.16%, closed at $1.63 and overall traded volume was 1.56 million shares while earning per share remains $0.07.

Krispy Kreme Doughnuts (NYSE: KKD) advanced by 4.69%, closed at $4.46 and overall traded volume was 1.40 million shares while earning per share remains $0.03.

Wendy’s Arby’s Group Inc. (NYSE:WEN) declined by 1.36%, closed at $4.34 and overall traded volume was 8.61 million shares while earning per share remains $0.02.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer ( http://pennytobuck.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyToBuck.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations.The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.